GLPG - Galapagos N.V. Qarzning balans kapitallashuviga nisbati

Galapagos N.V. (GLPG) grafik logotipi

Galapagos NV (GLPG) uchun ushbu kunlik narxlar grafigi Yevropa Ittifoqida narx belgilash imkoniyati hukumat tartibga soluvchilari tomonidan cheklangan aktivning narxlar dinamikasini aks ettiradi, bunda joriy ko'rsatkich 0.00 ni tashkil etadi. Biznes rivojlanish strategiyasining o'zgarishi va asosiy hamkorlar bilan aloqalarning potentsial uzilishi xavfi ostida qolgan. Biroq, hujayralar terapiyasi va kichik molekulalar sohasida nufuzli Yevropa brendi maqomi Galapagos NV (GLPG) shifokorlar orasida barqaror ishonchni saqlab qolishini ta'minlaydi.

GLPG (Galapagos Corp) Qarzning balans qiymatiga nisbati tarixi 04.07.2022dan 08.05.2026gacha

Galapagos N.V. (GLPG) - koʻrsatkichlar kesimi va moliyaviy hisobotlar

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya narxi Galapagos NV|GLPG - Tahlilchilar konsensus prognozi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor qiymati Galapagos Corp|GLPG - Qarz va naqd pullar hisobga olingan qiymat
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya uchun sof aktivlar Galapagos|GLPG - Kompaniyaning sof aktivlari|Bozor kapitallashuvining balans qiymatiga nisbati glpg.com|GLPG - Kompaniyaning umumiy aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Umumiy qarzning xususiy kapitalga nisbati Galapagos NV|GLPG - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning o'z kapitaliga nisbati Galapagos Genomics|GLPG - Kompaniyaning umumiy yig'indi qarzi|Qarzning balans qiymatiga nisbati Galapagos Corp
Kompaniyaning barcha koʻrsatkichlari tahlili:GLPG Galapagos NV
Galapagos Genomics asosiy tovari

Ushbu koeffitsient kompaniyaning umumiy majburiyatlarini uning kapitaliga solishtirib, moliyaviy leveraj darajasini va balans strukturasining umumiy barqarorligini aniqlaydi. Galapagos NV (GLPG) qarzdorligini uning kitob kapitalizatsiyasiga nisbatan tahlil qilish orqali investor qat'iy operatsion xarajatlar nazorati va royalti bog'liqligi sharoitida decentralizatsiyalashgan CAR-T platformasini rivojlantirish uchun xavfsizlik zaxirasini baholaydi.

Galapagos NV raqobatchilari

Balans kapitallashuviga qarzlar HLN (Haleon plc)|kenvue.com - Balans kapitallashuviga qarzlar|Qarzning balans kapitallashuviga nisbati Verona Pharma (VRNA)|MENS: Qarzning sof aktivlarga nisbati|LGND (Ligand Pharma) - Qarzning balans kapitallashuviga nisbati|Amneal Corp (AMRX) - Qarzning balans qiymatiga nisbati|PRGO (Perrigo Company plc) - Balans kapitallashuviga qarzlar|Balans kapitallashuviga qarzlar alvotech.com (ALVO)|Liquidia (LQDA) - Qarzning balans qiymatiga nisbati|Qarzning sof aktivlarga nisbati ANIP (ANI Pharmaceuticals Inc)|MNKD: Qarzning balans kapitallashuviga nisbati|AMPH - Balans qiymatiga qarzlar|Qarzning balans qiymatiga nisbati Pacira BioSciences PCRX|SPRY - Qarzning balans kapitaliga nisbati|Balans kapitallashuviga qarzlar Theravance Biopharma, Inc. TBPH|Aquestive Therapeutics Inc (AQST) - Qarzning sof aktivlarga nisbati|Balans kapitallashuviga qarzlar SCPH (scPharmaceuticals, Inc.)|Balans qiymatiga qarzlar TECX|Tonix Pharmaceuticals (TNXP) - Qarzning balans kapitallashuviga nisbati|Qarzning sof aktivlarga nisbati sxtchina.com (SXTC)|EPRX (Eupraxia Pharmaceuticals Inc.) - Balans kapitallashuviga qarzlar|Qarzning sof aktivlarga nisbati BioHarvest Sciences, Inc. BHST|Invizyne Technologies, Inc. - Balans kapitallashuviga qarzlar|ORMP: Balans kapitallashuviga qarzlar|enterabio.com (ENTX) - Qarzning balans kapitallashuviga nisbati|ipatherapeutics.com (HYFT) - Qarzning balans kapitallashuviga nisbati|ABVC (ABVC BioPharma, Inc.) - Balans kapitallashuviga qarzlar|Balans kapitallashuviga qarzlar CPIX|QNTM - Qarzning balans kapitallashuviga nisbati|Qarzlarning balans kapitallashuviga nisbati FibroGen Corporation (FGEN)|Balans kapitallashuviga qarzlar TELO (Telomir Pharmaceuticals)|Balans kapitallashuviga qarzlar Rani Therapeutics Holdings RANI|Balans kapitallashuviga qarzlar SNYR|RLYB: Qarzning sof aktivlarga nisbati|Qarzning balans kapitallashuviga nisbati LEXX|PULM (Pulmatrix Corporation) - Balans qiymatiga qarzlar|PTHL: Qarzning balans kapitallashuviga nisbati|Sof aktivlarga qarzlar Aptorum (APM)|Lyra Therapeutics (LYRA) - Qarzning balans qiymatiga nisbati|Qarzning sof aktivlarga nisbati IBO (Impact BioMedical, Inc.)|TNFA - Qarzning balans kapitallashuviga nisbati|YCBD - Qarzning balans qiymatiga nisbati|PRFX - Qarzning balans qiymatiga nisbati|CYTO - Qarzning balans kapitallashuviga nisbati|Balans kapitallashuviga qarzlar LIPO (Lipella Pharmaceuticals, Inc.)|OPTN (OptiNose Inc) - Qarzning sof aktivlarga nisbati|Qarzning balans kapitallashuviga nisbati Pieris|Qarzning balans kapitallashuviga nisbati PROC|PTPI - Qarzning balans kapitallashuviga nisbati|Qarzlarning balans kapitallashuviga nisbati qlsyy.net (QLI)|SLRN (ACELYRIN) - Balans kapitallashuviga qarzlar|TFF Pharmaceuticals Inc. - Qarzning sof aktivlarga nisbati